Navigation Links
Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
Date:1/26/2009

FAIRFIELD, N.J., Jan. 26 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company has entered into a Distributor Agreement with Perrigo Company (Nasdaq: PRGO), a leading manufacturer in the generic prescription marketplace, designating Perrigo as the Exclusive Authorized Distributor of generic versions of Medimetriks' branded products in the U.S. The agreement calls for Medimetriks to receive a percentage of Perrigo's Net Sales on the non-branded products, allowing Medimetriks to maximize its investment in its brands and maintain a revenue stream from the markets these brands create.

Founded in May, 2008, Medimetriks launched its first prescription brands in the 4th Quarter of 2008 to the Dermatology and Podiatry markets. These brands include Pacnex(TM) (7% Benzoyl Peroxide) Wash, a topical treatment for acne in a unique vehicle containing Aloe and Green Tea; Sumaxin(TM) (Sodium sulfacetamide 10% & sulfur 4%) Cleansing Pads, a topical treatment for acne and rosacea also in a vehicle containing Aloe and Green Tea; and Uramaxin(TM) (45% Urea) Nail Gel, a treatment for diseased and damaged nails in a unique vehicle containing Menthol, Camphor and Eucalyptus Oil. The agreement also includes future products launched by Medimetriks.

"Our agreement with Perrigo represents a strategic opportunity for Medimetriks to leverage our brand assets in the non-branded marketplace," stated Bradley Glassman, President and CEO of Medimetriks. "We are pleased to work with one of the world's leading healthcare manufacturers and generic marketers, with a particular expertise in the topical generic market."

"We believe our relationship with Medimetriks will be a mutually beneficial one," stated Sharon Kochan, Executive Vice President of Perrigo. "Medimetriks' Management Team, having previously built Br
'/>"/>

SOURCE Medimetriks Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
2. Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
3. Perrigo Announces FDA Final Approval for Ibuprofen PM
4. Perrigo Settles Desloratadine Patent Litigation
5. Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
6. Perrigo Announces FDA Tentative Approval for Ibuprofen PM
7. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
8. Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
9. Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
10. Perrigo Company Announces Appointment of New Board Member
11. Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... "The YogaForce A-Line Athletic Mat is grea... Weil, M.D., author and physician best known for e...ive medicine. Go to www.yogaforce.com and order...ift list. , San Francisco... the holidays, the YogaForce newly patented, revol...
(Date:11/28/2009)...Nov. 28 Get ready for advanced ...nical routine when Siemens introduces syngo...nnual Meeting of the Radiological Society of North...McCormick Place (Booth #825, East Building/Lakesid... , Siemens, new imaging software for multimodal...
(Date:11/28/2009)...elp lift spirits, recognize signs of depression ,...For many seniors, the holiday season can trigger m...uggle with health issues or worry about money prob.... , To help overcome the seasonal blues, the AG...ing advice: , Get out and socialize or invite fa...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued its la...c data. It shows that the lethality of the virus ... the virus,s current outbreak in the spring of 200...(s.d. 0.1). The H1N1 infectivity count, however, r...n (PRWEB) November 27, 2009 -- Biotech firm Replik...
(Date:11/27/2009)...N.Y., Nov. 27 Preventin...r and fortunately every year, new vaccines are bei...ll vaccines boost immunity for the same period of ...ots, needed to keep immunity strong? ,, In th... American Academy of Pediatrics, Michael Pichicher...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
...nsion journal suggests that increasing, dietary ...revention of hypertension, a major pu...e good sources of potassium and low in sodium ...Hypertension,concludes that an increase in potassi...
...olecular "smart bombs" to target metastasis with a...ficantly lower doses of toxic chemotherapy, with l...ding to a collaborative team of researchers at the...ector of Translational Research David Cheresh, Ph....
...ty HealthSystem,Consortium (UHC), welcomes Susan K...Chief Learning Officer. Dr. Pingleton has more tha...cine and comes to UHC from The,University of Kansa... Scholar in Residence at the Association of,Americ...
...sk for psychiatric disorders, study finds , ...lone isn,t associated with an increased risk of me...en suggested that pregnant women and those who,ve ...he study. , To determine whether this was true, th...
... trusted and,accessible health care providers, pha... and make more than 80 million recommendations to ...tients will follow these,recommendations. In fact,... purchase a particular OTC medicine based on,their...
...ny,(Nasdaq: PRGO ;TASE) announced today that Jose...t at the Oppenheimer & Co. Inc. 8th Annual Consume...m. (ET) at the Four Seasons,Hotel in Boston. The p...l healthcare supplier that develops,manufactures a...
Other Medicine News:Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 2Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 3Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 4Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 5Health News:'Smart bomb' nanoparticle strategy impacts metastasis 2Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2Health News:Pregnancy Alone Not A Risk for Mental Health Problems 2
(Date:11/29/2009)...and ST. LOUIS, Nov. 29 VIDA Diagno... software for the advanced analysis of pulmonary d...in minimally invasive delivery of interventional o...gned a definitive agreement covering joint develop...igation and biopsy system. ,, "Veran,s innovat...
(Date:11/29/2009)...RNewswire/ -- Stimulated by the ten years of Synap...al Systems USA announced today, at the Radiologica...the formation of its Medical Informatics Division...roup will integrate all functions associated with ...latform for future growth. ,, Several organizat...
(Date:11/28/2009)... Siemens Healthcare redefines prod...(Total imaging matrix) technology and with its new...technologies are introduced in the new MAGNETOM &#...ra* 3T scanners at the 95th Scientific Assembly an...rth America (RSNA) from November 29 to December 3 ...
Breaking Medicine Technology:VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Systems thinking and the obesity debate 10705 1Faithful mothers have healthier babies 10703 1Cornell Researchers Identify a Weak Link in Cancer Cell Armor 61240 1Cornell Researchers Identify a Weak Link in Cancer Cell Armor 61240 2
...a From 741-patient Trial Show Those Treated with L...t on Blood Pressure Compared,to Ibuprofen, EAST HA...s with,osteoarthritis who also have controlled hyp... daily blood pressure when treated with,the invest...mpared,to a slight increase in those taking ibupro...
...N, Pa., June 15, 2007 /PRNewswire/ -- Solstice,Neu...from a,multicenter, forced dose escalation study o...loc(R)) recently presented at the 11th,Internation...stanbul, Turkey. , This was the first multicenter ...calating treatment doses of 10,000 Units, 12,500,U...
Other Medicine Technology:Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 2Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 3Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 4
Ovation BioNatural Pipette, one-stroke, fixed volume, 300L
...nd value!, Comfortable feel and less hand fatigue...rol while pipetting with smooth, light plunger spr...ntamination and sterilization without the need for... for reproducible, accurate volume settings , Acc...
Pipetman F400
...Pipette is a synonym for pipetting accuracy, a smo...ior operating comfort. Its single, multifunctional...d blow-out as well as eject the tip. Product featu...accuracy and precision. Ejection sleeve can be rem...
Medicine Products: